Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19

Findings from this cohort study suggest that ADT use was not associated with decreased mortality from SARS-CoV-2 infection. However, large ongoing clinical trials will provide further evidence on the role of ADT or other androgen-targeted therapies in reducing COVID-19 infection severity.